Furthermore, it was observed that the diabetes- mediated suppression of PSD95, synaptophysin and synapsin-1 expressions in hippocampus were markedly reversed by GSK treatment, which is consistent with those in FGF1-treated group (Fig.8g). This evidence concerns the gene FGF1 and diabetes mellitus.